Cytokinetics (CYTK) Misses Q1 EPS by 19c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $74.13 +0.93%
Financial Fact:
Interest and other, net: 111K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Interest and other, net: 111K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q1 EPS of ($1.33), $0.19 worse than the analyst estimate of ($1.14). Revenue for the quarter came in at $840 thousand versus the consensus estimate of $1.05 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- SanDisk upgraded at JPMorgan after investor day; shares climb
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
